Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Cognition Disorders

5,7-dihydroxytryptamine has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertrand, F; Cassel, JC; Jeltsch, H; Lazarus, C; Lehmann, O; Morer, M; Will, B1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Cognition Disorders

ArticleYear
5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat.
    The European journal of neuroscience, 2002, Volume: 15, Issue:12

    Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Acetylcholinesterase; Animals; Antibodies, Monoclonal; Behavior, Animal; Cholinergic Agents; Cognition Disorders; Denervation; Drug Interactions; Hippocampus; Immunotoxins; Male; Maze Learning; Motor Activity; N-Glycosyl Hydrolases; Neural Pathways; Neurons; Postural Balance; Raphe Nuclei; Rats; Rats, Long-Evans; Ribosome Inactivating Proteins, Type 1; Saporins; Septal Nuclei; Serotonin; Serotonin Agents

2002